The rapid evolution of vaccine technology, driven by the unprecedented success of mRNA platforms during the COVID-19 pandemic, has fundamentally shifted our approach to protein-based vaccines. mRNA vaccines offer a...
The concentration of biomanufacturing expertise in industrial nations left low- and middle-income countries with few ways to obtain the COVID-19 vaccines when they became available. That limited availability (combined...